Determinants of gait speed in COPD

Chest

Volumn 146, Issue 1, 2014, Pages 104-110

  Karpman, Craig ^a   DePew, Zachary S ^a   LeBrasseur, Nathan K ^a   Novotny, Paul J ^a   Benzo, Roberto P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MIN WALK TEST; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DYSPNEA; EXERCISE; FEMALE; GAIT; GAIT SPEED; HEALTH CARE UTILIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MOOD; PATIENT CARE; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCREENING;

AGED; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; GAIT; HUMANS; MALE; MOTOR ACTIVITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; WALKING;

EID: 84903829005     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2017     Document Type: Article

References (44)

1. Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003; 51 (3): 314-322.
2. Cesari M, Kritchevsky SB, Penninx BWHJ, et al. Prognostic value of usual gait speed in well-functioning older peopleresults from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005; 53 (10): 1675-1680.
3. Fritz S, Lusardi M. White paper: "walking speed: the sixth vital sign. " J Geriatr Phys Th er. 2009; 32 (2): 46-49.
4. Montero-Odasso M, Schapira M, Soriano ER, et al. Gait veloc ity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci. 2005; 60 (10): 1304-1309.
5. Ostir GV, Berges I, Kuo YF, Goodwin JS, Ottenbacher KJ, Guralnik JM. Assessing gait speed in acutely ill older patients admitted to an acute care for elders hospital unit. Arch Intern Med. 2012; 172 (4): 353-358.
6. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011; 305 (1): 50-58.
7. Hardy SE, Perera S, Roumani YF, Chandler JM, Studenski SA. Improvement in usual gait speed predicts better survival in older adults. J Am Geriatr Soc. 2007; 55 (11): 1727-1734.
8. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011; 140 (2): 331-342.
9. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006; 61 (9): 772-778.
10. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009;33(2):262-272.
11. Polkey MI, Spruit MA, Edwards LD, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate End points (ECLIPSE) Study Investigators. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important diff erence for death or hospitalization. Am J Respir Crit Care Med. 2013; 187 (4): 382-386.
12. Kon SS, Patel MS, Canavan JL, et al. Reliability and validity of the 4-metre gait speed in COPD. Eur Respir J. 2013; 42(2):333-340.
13. Ilgin D, Ozalevli S, Kilinc O, Sevinc C, Cimrin AH, Ucan ES. Gait speed as a functional capacity indicator in patients with chronic obstructive pulmonary disease. Ann Th orac Med. 2011; 6 (3): 141-146.
14. Andersson M, Moberg L, Svantesson U, Sundblom A, Johansson H, Emtner M. Measuring walking speed in COPD: test-retest reliability of the 30-metre walk test and comparison with the 6-minute walk test. Prim Care Respir J. 2011;20(4):434-440.
15. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what? Clin Respir J. 2012;6(4):208-214.
16. Karpman C, LeBrasseur NK, DePew ZS, Novotny PJ, Benzo RP. Measuring gait speed in the out-patient clinic: methodology and feasibility. Respir Care. 2014; 59 (4): 531-537.
17. ATS Committee on Profi ciency Standards for Clinical Pul monary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166 (1): 111-117.
18. Manini TM, Everhart JE, Patel KV, et al. Daily activity energy expenditure and mortality among older adults. JAMA. 2006; 296 (2): 171-179.
19. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airfl ow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004; 350 (10): 1005-1012.
20. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54 (7): 581-586.
21. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dys pnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 158 (4): 1185-1189.
22. Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and diseasespecifi c quality of life following an acute COPD exacerbation. Chest. 2002; 121 (3): 688-696.
23. Locke DE, Decker PA, Sloan JA, et al. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage. 2007; 34 (6): 628-638.
24. Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005; 58 (2): 163-171.
25. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using selfreport assessment methods to explore facets of mindfulness. Assessment. 2006; 13 (1): 27-45.
26. Lowry KA, Brach JS, Nebes RD, Studenski SA, VanSwearingen JM. Contributions of cognitive function to straight- and curved-path walking in older adults. Arch Phys Med Rehabil. 2012; 93 (5): 802-807.
27. Rosano C, Newman AB, Katz R, Hirsch CH, Kuller LH. Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults. J Am Geriatr Soc. 2008; 56 (9): 1618-1625.
28. Inzitari M, Newman AB, Yaff e K, et al. Gait speed predicts decline in attention and psychomotor speed in older adults: the health aging and body composition study. Neuroepidemiology. 2007; 29 (3-4): 156-162.
29. DePew ZS, Karpman C, Novotny PJ, Benzo RP. Correlations between gait speed, 6-minute walk distance, physical activity, and self-effi cacy in patients with severe chronic lung disease. Respir Care. 2013;58(12):2113-2119.
30. Vestbo J, Hurd SS, AgustíAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187 (4): 347-365.
31. Spruit MA, Watkins ML, Edwards LD, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med. 2010; 104 (6): 849-857.
32. Szekely LA, Oelberg DA, Wright C, et al. Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. Chest. 1997; 111 (3): 550-558.
33. Lederer DJ, Arcasoy SM, Wilt JS, D'Ovidio F, Sonett JR, Kawut SM. Sixminute- walk distance predicts waiting list survival in idiopathic pulmonary fi brosis. A m J Respir Crit Care Med. 2006; 174 (6): 659-664.
34. Spruit MA, Polkey MI, Celli B, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2012; 13 (3): 291-297.
35. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Eft himiou J; International COPD Study Group. Multicentre randomised placebocontrolled trial of inhaled fl uticasone propionate in patients with chronic obstructive pulmonary disease. Lancet. 1998; 351 (9105): 773-780.
36. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23(1):28-33.
37. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic signifi cance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000; 161 (2 pt 1): 487-492.
38. Opasich C, Pinna GD, Mazza A, et al. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J. 2001; 22 (6): 488-496.
39. Benzo R, Siemion W, Novotny P, et al; National Emphy sema Treatment Trial Research Group. Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease. J Pain Symptom Manage. 2013; 46 (4): 491-499.
40. Herman CR, Gill HK, Eng J, Fajardo LL. Screening for preclinical disease: test and disease characteristics. AJR Am J Roentgenol. 2002; 179 (4): 825-831.
41. Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009; 13 (10): 881-889.
42. Li J, Huang Y, Fei GH. The evaluation of cognitive impairment and relevant factors in patients with chronic obstructive pulmonary disease. Respiration. 2013;85(2):98-105.
43. Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest. 2013;144(1):119-127.
44. Antonelli-Incalzi R, Corsonello A, Pedone C, et al. Drawing impairment predicts mortality in severe COPD. Chest. 2006; 130 (6): 1687-1694.